These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 20800018)
1. Recent progress in nanotechnology for cancer therapy. Tang MF; Lei L; Guo SR; Huang WL Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018 [TBL] [Abstract][Full Text] [Related]
2. NANOTECHNOLOGY - NEW TRENDS IN THE TREATMENT OF BRAIN TUMOURS. Krůpa P; Řehák S; Diaz-Garcia D; Filip S Acta Medica (Hradec Kralove); 2014; 57(4):142-50. PubMed ID: 25938897 [TBL] [Abstract][Full Text] [Related]
3. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems). Ruiz ME; Gantner ME; Talevi A Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193 [TBL] [Abstract][Full Text] [Related]
4. Cancer drug delivery in the nano era: An overview and perspectives (Review). Li Z; Tan S; Li S; Shen Q; Wang K Oncol Rep; 2017 Aug; 38(2):611-624. PubMed ID: 28627697 [TBL] [Abstract][Full Text] [Related]
5. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572 [TBL] [Abstract][Full Text] [Related]
9. Nanotechnology platforms and physiological challenges for cancer therapeutics. Kim KY Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621 [TBL] [Abstract][Full Text] [Related]
10. [Nanotechnologies for designing new medicines]. Couvreur P Biol Aujourdhui; 2012; 206(4):237-48. PubMed ID: 23419251 [TBL] [Abstract][Full Text] [Related]
11. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology. Xue X; Liang XJ Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039 [TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for anticancer drugs--new trends in nanomedicine. Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925 [TBL] [Abstract][Full Text] [Related]
13. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry]. Szebeni J Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticulate carriers: an emerging tool for breast cancer therapy. Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853 [TBL] [Abstract][Full Text] [Related]
15. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Li J; Liang H; Liu J; Wang Z Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895 [TBL] [Abstract][Full Text] [Related]
16. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. Bar-Zeev M; Livney YD; Assaraf YG Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic and diagnostic applications of nanoparticles. Youns M; Hoheisel JD; Efferth T Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146 [TBL] [Abstract][Full Text] [Related]
18. Circumventing tumor resistance to chemotherapy by nanotechnology. Liang XJ; Chen C; Zhao Y; Wang PC Methods Mol Biol; 2010; 596():467-88. PubMed ID: 19949937 [TBL] [Abstract][Full Text] [Related]
19. The new era of nanotechnology, an alternative to change cancer treatment. Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548 [TBL] [Abstract][Full Text] [Related]
20. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment. Ho BN; Pfeffer CM; Singh ATK Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]